论文部分内容阅读
目的:探讨静脉胺碘酮对急性心律失常的治疗价值和安全性。方法:将2010年1月到2011年12月我院收治的急性心律失常患者随机均分为两组,试验组静脉注射胺碘酮治疗,对照组则口服胺碘酮,对比两组患者疗效及安全性。结果:试验组总有效率97.62%,对照组76.19%,两组比较差异具有统计学意义,P<0.05。两组不良反应均较少,比较差异不明显。结论:静脉胺碘酮治疗急性心律失常疗效较好,安全可靠,值得临床推广应用。
Objective: To investigate the value and safety of intravenous amiodarone in the treatment of acute arrhythmia. Methods: January 2010 to December 2011 in our hospital admitted to patients with acute arrhythmia were randomly divided into two groups, the experimental group intravenous amiodarone treatment, the control group was orally administered amiodarone compared the efficacy of the two groups of patients and safety. Results: The total effective rate was 97.62% in the experimental group and 76.19% in the control group, the difference between the two groups was statistically significant (P <0.05). Two groups of adverse reactions are less, the difference was not obvious. Conclusion: Intravenous amiodarone is effective and safe in the treatment of acute arrhythmia, which is worthy of clinical application.